Related Experiment Video
Updated: Jan 7, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Active Tuberculosis Risk Associated with Malignancies: A 4-Year Retrospective Study in a Tertiary Care Hospital
Priyamvada Roy1, Kiran Bala1, Jaya Biswas1
1Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Tuberculosis (TB) is a significant risk for cancer patients, particularly those with lung, leukemia, gastrointestinal, and genitourinary cancers. Early screening and treatment for TB in these high-risk cancer populations are crucial for reducing mortality.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) poses a significant global public health challenge.
- Cancer patients face an elevated risk of TB reactivation or reinfection.
- This study examines TB incidence and outcomes in a tertiary care hospital setting.
Purpose of the Study:
- To assess the incidence of tuberculosis (TB) in cancer patients undergoing treatment.
- To identify specific cancer types with a higher risk of TB co-infection.
- To evaluate the effectiveness of diagnostic methods and patient outcomes.
Main Methods:
- Retrospective analysis of clinical samples from cancer patients with suspected TB.
- Utilized Ziehl-Neelsen (ZN) staining, GeneXpert MTB/RIF (Gx), TB polymerase chain reaction (PCR), and liquid culture (MGIT 960).
- Statistical analysis performed using Stata 14.0 with Pearson's chi-square test.
Main Results:
- Out of 906 patients, 42 (4.64%) were diagnosed with TB.
- GeneXpert (10.53%) and PCR (13.51%) showed higher detection rates than ZN staining (1.37%) and MGIT culture (6%).
- Lung cancer (28%), leukemia (25%), and gastrointestinal/genitourinary cancers (13% each) were most common among TB-positive patients. Mortality was highest in Hodgkin's lymphoma (75%).
Conclusions:
- Active TB is prevalent in cancer patients, particularly those with lung, leukemia, gastrointestinal, and genitourinary cancers.
- High mortality rates associated with TB in Hodgkin's lymphoma patients underscore the need for vigilance.
- Targeted TB screening at cancer diagnosis and periodically during treatment is recommended for high-risk cancer patients.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders

